Experiences of a long-term randomized controlled prevention trial in a maiden environment: Estonian Postmenopausal Hormone Therapy trial
<p>Abstract</p> <p>Background</p> <p>Preventive drugs require long-term trials to show their effectiveness or harms and often a lot of changes occur during post-marketing studies. The purpose of this article is to describe the research process in a long-term randomized...
Main Authors: | Rahu Mati, Veerus Piret, Hovi Sirpa-Liisa, Hemminki Elina |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-08-01
|
Series: | BMC Medical Research Methodology |
Online Access: | http://www.biomedcentral.com/1471-2288/8/51 |
Similar Items
-
Who wants to join preventive trials? – Experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757]
by: Veerus Piret, et al.
Published: (2005-04-01) -
Symptom reporting and quality of life in the Estonian Postmenopausal Hormone Therapy Trial
by: Rahu Mati, et al.
Published: (2008-03-01) -
The effects of postmenopausal hormone therapy on social activity, partner relationship, and sexual life – experience from the EPHT trial
by: Hemminki Elina, et al.
Published: (2009-06-01) -
Results from a blind and a non-blind randomised trial run in parallel: experience from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial
by: Veerus Piret, et al.
Published: (2012-04-01) -
Variability of bothersome menopausal symptoms over time – a longitudinal analysis using the Estonian postmenopausal hormone therapy trial (EPHT)
by: Hemminki Elina, et al.
Published: (2012-12-01)